UT Horizon Fund Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 1
Professionals
  • Investments
  • 36
  • Portfolio
  • 11
  • Exits
  • 11
Exits

UT Horizon Fund General Information

Description

The UT Horizon Fund is the strategic venture capital investment fund of The University of Texas System. The fund primarily invests in early and mid stage companies that are commercializing technologies arising out of UT System's 14 institutions.

Contact Information

Year Founded
2011
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • The University of Texas System
  • 210 West 7th Street
  • Austin, TX 78701
  • United States
+1 (512) 000-0000

UT Horizon Fund Investments (36)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Decisio 14-Feb-2022 Later Stage VC 000.00 Decision/Risk Analysis Generating Revenue 000 0000000
0000 000000000000 31-Oct-2019 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 000 0000000
0000000 0000000000 18-Apr-2019 00000 00000 00.00 Therapeutic Devices Generating Revenue
0000000 11-Feb-2019 00000 00000 00.00 Decision/Risk Analysis Generating Revenue 000 0000000
00000000 20-Nov-2017 00000 00000 000 Wireless Communications Equipment Generating Revenue 000 0000000
000000000 00000000 28-Jul-2017 0000 00000 00.000 Drug Discovery Pre-Clinical Trials
00000000 20-Jun-2017 0000 00000 00.00 Wireless Communications Equipment Generating Revenue 0000 000000
0000000000 01-May-2017 0000 00000 000 Therapeutic Devices Out of Business
M87 17-Nov-2016 Later Stage VC 00.000 Wireless Communications Equipment Generating Revenue
Alafair Biosciences 09-Aug-2016 Early Stage VC 000 Therapeutic Devices Generating Revenue 00000 000000000000
You’re viewing 10 of 36 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

UT Horizon Fund Exits (11)

Company Name Exit Date Exit Type Exit Size
Cerevast 01-Jul-2021 Secondary Transaction - Private
0000000 01-Apr-2021 000000000 00000000
0000000000 0000000 01-Dec-2019 000 00 00000000
0000000000 01-Jul-2019 000 00 00000000
000 26-Mar-2019 000000000000000000 0000
000000000 000000 08-Jun-2017 000000000000000000 000
000000 00000000000 07-Apr-2016 000 0000
0000000 0000000000 07-Mar-2016 000000000000000000 000
Lynx Laboratories 18-Nov-2015 Merger/Acquisition
Apollo Endosurgery Secondary Transaction - Open Market
You’re viewing 10 of 11 exits. Get the full list »

UT Horizon Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

UT Horizon Fund Team (11)

Name Title Deals Funds Boards Office
Julie Goonewardene Managing Director and Chief Innovation Officer 0 Austin, TX
Matt Sorenson Innovation Program Manager Austin, TX
Gus Johnson Assistant Director 0 0 0 Austin, TX
Phyllis Whiteley Ph.D Advisor 0 0 0 Austin, TX
Stacy Feld JD Advisor 0 0 0 Austin, TX
You’re viewing 5 of 11 team members. Get the full list »

UT Horizon Fund Co-Investors (5)

Name With Exits Lead Partner Series Industry
Bios Partners 1 0 Series chart Industry bar
DEFTA Partners 0 0 Series chart Industry bar
Declatex 0 0 Series chart Industry bar
GE Healthcare 0 0 Series chart Industry bar
Pioneer MPW 0 0 Series chart Industry bar
To view UT Horizon Fund’s complete co-investors history, request access »